The global Microfluidics market was valued at USD 23.71 billion in 2024 and stood at USD 24.96 billion in 2025. The market is projected to advance at a CAGR of 8.3% from 2025 to 2030, reaching USD 37.19 billion by 2030. The growth of the microfluidics market is driven by the increasing demand for point-of-care diagnostics, which require rapid, accurate, and cost-effective instruments. The growing adoption of personalized medicine is also increasing the need for precise biomarker analysis, miniaturized diagnostic platforms, and high-throughput screening technologies.
Increasing research and development expenditure is further supporting innovation in microfluidic technologies and expanding their applications across diagnostics, pharmaceutical research, life sciences, drug discovery, and molecular biology. The ability of microfluidic systems to process small sample volumes, integrate multiple analytical steps, improve testing efficiency, and support miniaturized laboratory workflows is contributing to their growing adoption across healthcare and research applications.
Spotlights on the Industry’s Leading Microfluidics Companies
The microfluidics industry is evolving as healthcare and life sciences organizations seek faster, more efficient, and increasingly integrated analytical technologies. Companies operating in this market are developing solutions spanning microfluidic chips, instruments, pumps, valves, diagnostic systems, molecular analysis platforms, laboratory automation, and point-of-care technologies.
1. Abbott Laboratories (US)
Abbott Laboratories develops diagnostic technologies and systems that incorporate microfluidic principles across various healthcare applications. The company’s diagnostic portfolio supports decentralized and point-of-care testing where rapid and reliable results are important for clinical decision-making.
The increasing demand for compact diagnostic platforms and near-patient testing is creating opportunities for microfluidics-based technologies, particularly in applications requiring efficient sample handling and integrated analysis.
2. Agilent Technologies Inc. (US)
Agilent Technologies provides analytical instruments, laboratory technologies, consumables, and solutions that support microfluidics-related research and applications. Its technologies are used across life sciences, diagnostics, pharmaceutical research, and chemical analysis.
The company’s capabilities support researchers working with miniaturized analytical workflows, molecular analysis, and high-throughput applications where precision and efficient sample utilization are important.
3. Aignep S.P.A (Italy)
Aignep provides fluid handling and pneumatic technologies, including components used for controlling and managing fluid movement in industrial and laboratory environments. These technologies are relevant to microfluidic systems where accurate fluid control is essential.
The increasing integration of pumps, valves, connectors, and fluid management components into microfluidic platforms creates opportunities for specialized fluid-handling technologies across research and industrial applications.
4. bioMérieux (France)
bioMérieux develops diagnostic solutions for infectious diseases, clinical microbiology, and molecular diagnostics. The company’s diagnostic technologies contribute to the broader adoption of automated and miniaturized testing workflows.
Microfluidics can support the integration of sample preparation, reagent handling, and analytical processes within compact diagnostic platforms, aligning with the growing demand for rapid and decentralized diagnostics.
5. BD (US)
BD provides medical technology, diagnostic, laboratory, and life sciences solutions supporting research and clinical applications. Its technologies contribute to workflows involving sample preparation, cell analysis, molecular testing, and laboratory automation.
The increasing demand for integrated diagnostic and analytical systems creates opportunities for microfluidic technologies to improve sample handling, testing speed, and workflow efficiency.
6. Bio-Rad Laboratories Inc. (US)
Bio-Rad Laboratories provides life sciences research and diagnostic technologies, including solutions supporting digital biology, molecular analysis, and laboratory research. Its technologies address applications where precise sample processing and high-throughput analysis are required.
Microfluidic technologies can enhance miniaturized workflows by reducing reagent consumption and enabling the integration of multiple analytical steps, supporting applications across molecular diagnostics and research.
7. Danaher Corporation (US)
Danaher Corporation participates in the microfluidics ecosystem through its life sciences, diagnostics, and biotechnology businesses. Its portfolio encompasses technologies used for molecular diagnostics, cell analysis, laboratory automation, and bioprocessing.
The company’s broad presence across healthcare and life sciences positions it to benefit from the increasing adoption of integrated and automated microfluidic platforms.
8. Illumina Inc. (US)
Illumina provides sequencing and genomic analysis technologies that rely on highly controlled fluid handling and miniaturized analytical processes. Its platforms support applications across genomics, molecular biology, clinical research, and precision medicine.
As demand increases for high-throughput sequencing and advanced genomic analysis, microfluidic technologies can support efficient reagent management, sample processing, and system integration.
9. Parker Hannifin Corporation (US)
Parker Hannifin provides motion and control technologies, including fluid handling components, precision pumps, valves, fittings, and other technologies relevant to microfluidic systems.
Its fluid management capabilities support applications where precise control of extremely small fluid volumes is required, including laboratory instrumentation, diagnostic systems, and analytical platforms.
10. Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific offers a broad portfolio of analytical instruments, laboratory equipment, consumables, and life sciences technologies supporting microfluidics-related applications.
Its solutions serve pharmaceutical, biotechnology, academic, and clinical laboratories, where miniaturized sample processing, automated analysis, molecular testing, and high-throughput workflows are increasingly important.
11. SMC Corporation (Japan)
SMC Corporation provides automation and fluid control technologies, including valves, fittings, actuators, and pneumatic components. These technologies can support microfluidic and laboratory automation systems requiring precise fluid movement and process control.
The company’s expertise in automation and fluid handling aligns with the increasing integration of automated fluid management into analytical and diagnostic platforms.
12. IDEX Corporation (US)
IDEX Corporation provides precision fluidics and fluid-handling technologies used across healthcare, life sciences, analytical instrumentation, and industrial applications.
Its portfolio includes pumps, valves, fittings, and other fluid management technologies that can enable precise and reliable fluid movement in microfluidic and laboratory systems.
13. Fortive Corporation (US)
Fortive operates across healthcare, instrumentation, automation, and related technology markets. Its businesses provide technologies supporting measurement, diagnostics, laboratory operations, and industrial process control.
The company’s presence in precision instrumentation and workflow technologies provides opportunities to participate in the broader development of automated and integrated analytical systems incorporating microfluidic technologies.
14. PerkinElmer Inc. (US)
PerkinElmer provides technologies for diagnostics, life sciences, drug discovery, and research applications. Its portfolio supports workflows involving molecular analysis, screening, and laboratory testing.
Microfluidics-based systems can enhance these applications by enabling miniaturized testing, efficient sample utilization, and integrated analytical workflows, particularly in high-throughput research and diagnostic applications.
15. F. Hoffmann-La Roche Ltd. (Switzerland)
F. Hoffmann-La Roche develops diagnostic and life sciences technologies used across clinical diagnostics, molecular testing, and personalized healthcare. The company’s diagnostic platforms support the growing need for rapid and reliable analysis.
Microfluidic technologies are increasingly relevant to molecular diagnostics and integrated testing platforms because they enable precise fluid manipulation and the miniaturization of complex laboratory processes.
16. Standard BioTools Inc. (US)
Standard BioTools provides technologies for single-cell analysis, mass cytometry, genomics, and multi-omics research. Its platforms support researchers investigating cellular and molecular characteristics at increasingly high resolution.
Microfluidics plays an important role in enabling miniaturized and high-throughput biological analysis, supporting applications such as single-cell research, biomarker analysis, and advanced molecular profiling.
17. QuidelOrtho Corporation (US)
QuidelOrtho develops diagnostic testing technologies supporting infectious disease, immunodiagnostics, molecular diagnostics, and point-of-care applications.
The growing requirement for rapid decentralized testing creates opportunities for compact and integrated diagnostic technologies, including microfluidic approaches that can combine sample preparation and analysis within streamlined systems.
18. Hologic Inc. (US)
Hologic provides diagnostic and healthcare technologies with a strong focus on women’s health, molecular diagnostics, and screening applications. Its diagnostic systems support the detection and management of various diseases and health conditions.
Microfluidic technologies can contribute to the development of compact diagnostic platforms capable of delivering rapid and automated molecular testing while improving workflow efficiency.
19. Dolomite Microfluidics (UK)
Dolomite Microfluidics specializes in microfluidic technologies, including microfluidic chips, pumps, modules, and systems for research and development applications.
The company’s solutions support applications such as droplet generation, single-cell analysis, drug discovery, diagnostics, and particle production. Its specialized microfluidics portfolio positions it within the development of increasingly sophisticated laboratory-on-a-chip and automated research platforms.
20. Elveflow (France)
Elveflow develops microfluidic flow control systems, including pressure controllers, flow controllers, pumps, and related technologies for research applications.
Its solutions enable precise control of fluids at the microscale and support applications in cell biology, organ-on-chip research, drug discovery, diagnostics, and microfluidic device development.
Conclusion:
The Microfluidics market is expanding as healthcare and life sciences organizations increasingly adopt miniaturized, automated, and integrated analytical technologies. Rising demand for point-of-care diagnostics, personalized medicine, biomarker analysis, high-throughput screening, and advanced research platforms is creating new opportunities for microfluidic technologies across clinical and research applications.
For deeper insights into the Microfluidics Market, including market size and growth, technology trends, applications, competitive landscape, regional opportunities, market segmentation, emerging developments, and growth prospects through 2030, access the complete market report.
